PLEKHA1 and head and neck squamous cell carcinoma: To investigate the clinical importance of PLEKHA1-TACC2, we collected the clinical characteristics of ESCC and HNSCC patients and divided the patients into two groups based on PLEKHA1-TACC2 expression (Tables S1–2).